Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma

被引:73
作者
Morrison, AM
Jäger, U
Chott, A
Schebesta, M
Haas, OA
Busslinger, M
机构
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Univ Vienna, Sch Med, Vienna, Austria
[3] St Anna Childrens Hosp, A-1090 Vienna, Austria
关键词
D O I
10.1182/blood.V92.10.3865.422k01_3865_3878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The PAX-5 gene codes for the transcription factor BSAP, which is expressed throughout B-cell development. Although loss-of-function mutation in the mouse showed an essential role for Pax-5 in early B lymphopoiesis, gain-of-function mutations have implicated the human PAX-5 gene in the control of late B-cell differentiation. PAX-5 (on 9p13) has been involved together with the immunoglobulin heavy-chain (IgH) gene (on 14q32) in the recurring t(9;14)(p13:q32) translocation that is characteristic of small lymphocytic lymphoma with plasmacytoid differentiation. Here we have characterized a complex t(2;9;14)(p12;p13;q32) translocation present in a closely related non-Hodgkin's lymphoma referred to as splenic marginal zone lymphoma (MZL). In this MZL-1 translocation, the two promoters of PAX-5 were replaced on the derivative chromosome 14 by an immunoglobulin switch S mu promoter that was linked to the structural PAX-C gene upstream of its translation initiation codon in exon 1B. Expression analyses confirmed that PAX-5 transcription was upregulated due to efficient initiation at the S mu promoter in the malignant B lymphocytes of patient MZL-1. For comparison we have analyzed PAX-5 expression in another B-cell lymphoma, KIS-1, indicating that transcription from the distal PAX-5 promoter was increased in this tumor in agreement with the previously characterized translocation of the immunoglobulin E mu enhancer adjacent to PAX-5 exon 1A. In both lymphomas, the J-chain gene, which is thought to be under negative control by BSAP, was not expressed, whereas transcription of the putative target gene p53 was unaffected by PAX-5 overexpression. Together these data indicate that the t(9;14)(p13;q32) translocation contributes to lymphoma formation as a regulatory mutation that leads to increased PAX-B expression in late B-cell differentiation due to promoter replacement or enhancer insertion. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:3865 / 3878
页数:14
相关论文
共 55 条
[1]   PAX-5 ENCODES THE TRANSCRIPTION FACTOR BSAP AND IS EXPRESSED IN LYMPHOCYTES-B, THE DEVELOPING CNS, AND ADULT TESTIS [J].
ADAMS, B ;
DORFLER, P ;
AGUZZI, A ;
KOZMIK, Z ;
URBANEK, P ;
MAURERFOGY, I ;
BUSSLINGER, M .
GENES & DEVELOPMENT, 1992, 6 (09) :1589-1607
[2]   Physiological activation of the IgH 3' enhancer in B lineage cells is not blocked by Pax-5 [J].
Andersson, T ;
Neurath, MF ;
Grant, PA ;
Pettersson, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) :2499-2507
[3]  
APEL TW, 1992, ONCOGENE, V7, P1267
[4]   The enhancer shift: a model to explain the developmental control of IgH gene expression in B-lineage cells [J].
Arulampalam, V ;
Eckhardt, L ;
Pettersson, S .
IMMUNOLOGY TODAY, 1997, 18 (11) :549-554
[5]   A NOVEL B-CELL LINEAGE-SPECIFIC TRANSCRIPTION FACTOR PRESENT AT EARLY BUT NOT LATE STAGES OF DIFFERENTIATION [J].
BARBERIS, A ;
WIDENHORN, K ;
VITELLI, L ;
BUSSLINGER, M .
GENES & DEVELOPMENT, 1990, 4 (05) :849-859
[6]  
BATRA SK, 1991, J BIOL CHEM, V266, P6830
[7]   Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma [J].
Bergsagel, PL ;
Chesi, M ;
Nardini, E ;
Brents, LA ;
Kirby, SL ;
Kuehl, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13931-13936
[8]   PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PROMOTER-SPECIFIC TRANSCRIPTION FACTOR, SPL [J].
BRIGGS, MR ;
KADONAGA, JT ;
BELL, SP ;
TJIAN, R .
SCIENCE, 1986, 234 (4772) :47-52
[9]   BETA+ THALASSEMIA - ABERRANT SPLICING RESULTS FROM A SINGLE POINT MUTATION IN AN INTRON [J].
BUSSLINGER, M ;
MOSCHONAS, N ;
FLAVELL, RA .
CELL, 1981, 27 (02) :289-298
[10]   Deregulation of PAX-5 by translocation of the E mu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma [J].
Busslinger, M ;
Klix, N ;
Pfeffer, P ;
Graninger, PG ;
Kozmik, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :6129-6134